18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder
Clinical trial NCT03902613 · COMPLETED
Trial details
- NCT number
- NCT03902613
- Sponsor
- New York State Psychiatric Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-07
- Primary completion
- 2019-08-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.